• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . The Model for End-Stage Liver Disease (MELD) Score Predicting Mortality Due to SARS-CoV-2 in Mexican Patients

tetano

Editor, Senior Moderator
J Clin Med


. 2024 Sep 27;13(19):5777.
doi: 10.3390/jcm13195777. The Model for End-Stage Liver Disease (MELD) Score Predicting Mortality Due to SARS-CoV-2 in Mexican Patients

José Manuel Reyes-Ruiz[SUP] 1 [/SUP], Ana Citlali Avelino-Santiago[SUP] 1 [/SUP], Gustavo Martínez-Mier[SUP] 1 [/SUP], Claudia Vanessa López-López[SUP] 2 3 [/SUP], Luis Adrián De Jesús-González[SUP] 4 [/SUP], Moises León-Juárez[SUP] 5 [/SUP], Juan Fidel Osuna-Ramos[SUP] 6 [/SUP], Carlos Noe Farfan-Morales[SUP] 7 8 [/SUP], Selvin Noé Palacios-Rápalo[SUP] 9 [/SUP], Víctor Bernal-Dolores[SUP] 1 [/SUP], Rosa María Del Ángel[SUP] 8 [/SUP]



Affiliations
Abstract

Background/Objectives: Coronavirus Disease 2019 (COVID-19) can cause liver injury and a deterioration of hepatic function. The Model for End-Stage Liver Disease (MELD) score is a good predictor for poor prognosis of hospitalized COVID-19 patients in the United States, Egypt and Turkey. Nevertheless, the best cut-off value for the MELD score to predict mortality in the Mexican population has yet to be established. Methods: A total of 234 patients with COVID-19 were studied in a tertiary-level hospital. Patients were stratified into survivors (n = 139) and non-survivors (n = 95). Receiver operating characteristic curves, Cox proportional hazard models, Kaplan-Meier method, and Bonferroni corrections were performed to identify the predictors of COVID-19 mortality. Results: MELD score had an area under the curve of 0.62 (95% CI: 0.56-0.68; p = 0.0009), sensitivity = 53.68%, and specificity = 73.38%. Univariate Cox proportional hazard regression analysis suggested that the leukocytes > 10.6, neutrophils > 8.42, neutrophil-to-lymphocyte ratio (NLR) > 8.69, systemic immune-inflammation index (SII) > 1809.21, MELD score > 9, and leukocyte glucose index (LGI) > 2.41 were predictors for mortality. However, the multivariate Cox proportional hazard model revealed that only the MELD score >9 (Hazard Ratio
= 1.83; 95% confidence interval [CI]: 1.2-2.8; P[SUB]corrected[/SUB] = 0.03) was an independent predictor for mortality of COVID-19. Conclusions: Although the MELD score is used for liver transplantation, we suggest that a MELD score >9 could be an accurate predictor for COVID-19 mortality at admission to ICU requiring mechanical ventilation.

Keywords: COVID-19; SARS-CoV-2; biomarker; model for end-stage liver disease (MELD) score; mortality.

 
Back
Top Bottom